top of page
.png)
Oncology Updates - Key Oncology News
September 1st Week, 2025 Regulatory Events 🎯 China’s NMPA approved Boehringer Ingelheim ’s zongertinib (HER2-selective tyrosine kinase...
Oncofocus Team
Sep 162 min read
Onco-Summaries: Daily Oncology Updates at a Glance
03/09/2025 Boehringer Ingelheim's zongertinib received the FDA Breakthrough Therapy Designation for first-line HER2-mutant advanced NSCLC...
Oncofocus Team
Sep 41 min read
Onco-Summaries: Daily Oncology Updates at a Glance
01/09/2025 Boehringer’s zongertinib received accelerated approval in China for HER2-mutant advanced NSCLC ( Ref ) China’s National...
Oncofocus Team
Sep 21 min read
bottom of page